The ENA virtual meeting 2020
The ENA virtual meeting 2020
Adagrasib in advanced/metastatic NSCLC with KRAS G12C mutation
Development of novel inhibitors of KRASG12C
Impact of angiotensin II pathway inhibition on tumour response to anti PD(L)1 based therapy
Managing multiple myeloma during the COVID-19 pandemic in Brazil
Updates in surgical oncology from SIOG 2020
Inter-laboratory concordance in clinical trials
Critical issues in drug and biomarker development
OncoAlert and ecancer weekly roundup for October 26 - 31, 2020
Extreme hypofractionation with stereotactic body radiation therapy for elderly patients
Updates in radiation oncology from SIOG 2020
Pragmatic geriatric assessment for cancer patients in Brazil